Galectins are a group of animal lectins characterized by their specificity for β-galactosides. Mouse galectin-2 (mGal-2) is predominantly expressed in the gastrointestinal tract and has been identified as one of the main gastric mucosal proteins that are uniquely sensitive to S-nitrosylation. We have previously reported that oxidation of mGal-2 by hydrogen peroxide (H 2 O 2 ) resulted in the loss of sugar-binding ability, whereas pretreatment of mGal-2 with S-nitrosocysteine prevented H 2 O 2 -induced inactivation. In this study, we used point-mutated recombinant mGal-2 proteins to study which of the two highly conserved Cys residues in mGal-2 must be S-nitrosylated for protection against oxidative inactivation. Mutation of Cys 57 to a Met residue (C57M) did not result in lectin inactivation following H 2 O 2 treatment, whereas Cys 75 mutation to Ser (C75S) led to significantly reduced lectin activity, as is the case for wild-type mGal-2. However, pretreatment of the C75S mutant with S-nitrosocysteine protected the protein from H 2 O 2 -induced inactivation. Therefore, Cys 57 is suggested to be responsible for oxidative inactivation of the mGal-2 protein, and protection of the sulfhydryl group of the Cys 57 in mGal-2 by S-nitrosylation is likely important for maintaining mGal-2 protein function in an oxidative environment such as the gastrointestinal tract.
Introduction
Galectins comprise a group of animal lectins that specifically bind to β-galactosides and are characterized by an evolutionarily conserved amino acid sequence motif in the carbohydrate-binding site (1) (2) (3) . Galectins are known to be involved in a wide variety of biological processes including development, cell differentiation, tumor metastasis, apoptosis, RNA splicing, and immune regulation (4, 5) .
Among the galectins, galectin-2 (Gal-2) was first identified to be highly expressed in gastric cells, predominantly in epithelial cells of the rat stomach (6). Gastric mucous cells exhibit strong Gal-2 immunoreactivity, with expression observed in the small intestine (7); GAL2 mRNA has also been detected in the human stomach (8) . Taken together, the expression of Gal-2 in the gastrointestinal tract and the amelioration of acute and chronic colitis in mice by Gal-2 overexpression (9) as well as the reduced expression of human Gal-2 associated with lymph node metastasis in gastric cancer (10) and in Helicobacter-induced gastric cancer progression (11) have suggested that Gal-2 exerts a protective function in the gastrointestinal tract.
Gal-2 was identified in a screen of mouse gastric mucosal proteins that are uniquely sensitive to Snitrosylation (12) . This process, which involves the coupling of an NO group to the reactive thiol of a cysteine (Cys) residue in a polypeptide, is known to be an important post-translational modification in a variety of proteins (13) . In addition to the NO generated enzymatically by NO synthase (NOS) from L-arginine by various cells including neurons and vascular endothelial cells, in which it functions as a signaling molecule, large quantities of NO are known to be generated in the stomach by nonenzymatic acid reduction of salivary nitrite to exert various physiological functions in the gastrointestinal tract (14) (15) (16) (17) including as a barrier in the stomach (18) (19) (20) . Several studies, including a study demonstrating that nitrate administration ameliorates dextran sulfate sodium-induced acute experimental colitis in mice (21) , have suggested that the NO generated in the gastrointestinal tract might also have a protective role therein.
In contrast, reactive oxygen species (ROS) such as hydrogen peroxide (H 2 O 2 ) can cause oxidative stress that could result in variety of disorders in the gastrointestinal tract including ulcers, 4 inflammatory bowel disease, and gastric and colorectal cancer (22) . In our previous report (23), we found that although oxidation of mouse galectin-2 (mGal-2) by H 2 O 2 resulted in the loss of sugarbinding activity, mGal-2 pretreatment with S-nitrosocysteine (CysNO) to effect S-nitrosylation prevented the H 2 O 2 -induced inactivation, presumably by protecting the Cys residues (Cys  57 and Cys   75   ) in the protein that are highly conserved across mammals (24) . Furthermore, analysis of mGal-2 proteins with site-directed mutations at the Cys 57 and /or Cys 75 positions suggested that both Cys residues were fully S-nitrosylated (23) . In this report, we utilized wild-type and mutant forms of mGal-2 to investigate which of the two Cys residues in mGal-2 is responsible for its inactivation by H 2 O 2 -induced oxidation.
Materials and Methods

Expression and purification of recombinant mGal-2
The expression and purification of recombinant wild-type Gal-2 and the three mutated forms of mGal-2, C57M (Cys 57 mutated to Met), C75S (Cys 75 mutated to Ser), and C57M/C75S (Cys  57 and Cys   75 mutated to Met and Ser, respectively), were performed as previously described (23) .
Measurement of protein concentration
Protein concentration was determined by Bradford's method (25) using bovine serum albumin as a standard.
Pretreatment reaction of recombinant mGal-2 proteins with CysNO for S-nitrosylation
The S-nitrosylation of the wild type and mutated forms of mGal-2 protein was performed as previously described (23) . To remove unreacted CysNO, samples were ultrafiltered using Amicon Ultra centrifuge tubes (Millipore, Billerica, MA, USA).
Saville-Griess assay
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The number of S-nitrosylated molecules was measured using the Saville-Griess assay as previously described (23, 26) .
Oxidation of mGal-2 by H 2 O 2
The H 2 O 2 concentration was measured at 240 nm (ε 240 = 43.6 L/mol·cm). S-nitrosylated mGal-2 was incubated with 10 mM H 2 O 2 for 2 h in the dark (23) .
Binding of Gal-2 recombinant proteins to lactose after treatment with H 2 O 2
C57M and C75S were treated with H 2 O 2 and then subjected to a lactose-immobilized agarose (J-Oil Mills, Inc., Tokyo, Japan) column (bed volume 1 ml) as previously described (23) . C75S was also pretreated with CysNO, followed by reaction with H 2 O 2 , and subjected to a lactose-immobilized agarose column as well.
Hemagglutination assay
The hemagglutination activity of the recombinant mGal-2 proteins was measured as previously reported (23, 27) . Briefly, a 25-μl sample of mGal-2 treated with CysNO and/or H 2 O 2 was serially diluted 2-fold in a 96-well V-shaped microtiter plate, followed by the addition of 50 μl of EDTA-PBS and 25 μl of 4% (v/v) glutaraldehyde-fixed rabbit erythrocytes in EDTA-PBS. After the samples were allowed to stand for 1 h at room temperature, the end-point showing the minimum concentration resulting in hemagglutination was determined.
Circular dichroism (CD) spectra of recombinant mGal-2 mutants
The CD spectra of recombinant proteins at the concentration of 0.25 mg/ml in EDTA-PBS with or without 10 mM H 2 O 2 were obtained using a J-720WI spectropolarimeter (JASCO Corporation, Tokyo, Japan).
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SDS-PAGE under non-reducing and reducing conditions
The recombinant wild-type mGal-2 protein and its mutant forms, C57M, C75S, or C57M/C75S, were treated with or without H 2 O 2 for 2 h in EDTA-PBS buffer. After the addition of catalase to quench the activity of the H 2 O 2 , sample buffer for SDS-PAGE with or without β-mercaptoethanol was added to the reaction mixture and the samples were incubated for 10 min at 70°C and subsequently subjected to SDS-PAGE. The gels were stained with Coomassie brilliant blue.
Crosslinking reaction using bis(sulfosuccinimidyl)suberate (BS
)
The crosslinking reaction to detect multimer formation of the recombinant galectins using the BS 3 crosslinking reagent (Thermo Fisher Scientific Inc., Waltham, MA, USA) was performed as previously described (23), with some modifications. Briefly, after the S-nitrosylation reaction, recombinant mGal-2 (5 µg in 50 µL) was incubated with 0.3 mM BS 3 for 30 min in EDTA-PBS at room temperature. Samples were resolved by SDS-PAGE, and the gel was stained with Oriole stain (Bio-Rad).
Results
Binding capacity of recombinant mGal-2 to lactose
Recombinant wild-type mGal-2 was adsorbed to a lactose-immobilized agarose column and eluted with 0.1 M lactose. Oxidation of mGal-2 by H 2 O 2 resulted in the loss of this binding ability and the recombinant mGal-2 ended up in the flow-through fraction, whereas pretreatment of mGal-2 with
CysNO prior to the reaction with H 2 O 2 prevented this binding inactivation and resulted in the generation of a lactose-eluted fraction (23) . In this report, we used site-directed mutants of mGal-2, C57M, and C75S, and determined their susceptibility to H 2 O 2 -induced oxidation. To obtain the recombinant protein of the two mutants, C57M and C75S, recombinant proteins were expressed in E.
coli and were subjected to a asialofetuin-immobilized agarose column with elution in 0.1 M lactose (data not shown) as described previously (23).
When recombinant C57M and C75S mGal-2 proteins were subjected to the lactose-immobilized agarose column after H 2 O 2 treatment, only the C57M mGal-2 protein was adsorbed to the column and eluted with lactose ( Fig. 1A ). In contrast, as was the case for the wild-type mGal-2, the C75S mutant seemed to lose substantial ability to interact with immobilized lactose upon H 2 O 2 treatment, and a large amount of the recombinant protein was observed in the flow-through fraction (Fig. 1B) .
However, when this C75S protein was pretreated with CysNO prior to the reaction with H 2 O 2 , the effect of H 2 O 2 treatment disappeared, and the protein was adsorbed to the column and eluted with lactose (Fig. 1C) ; this outcome was the same as that observed for the wild-type mGal-2 treated with CysNO (23).
Hemagglutination activity
Similar to the results of the binding assay, the C57M mutant form of mGal-2 retained its hemagglutination activity after treatment with H 2 O 2 , whereas the wild-type form of mGal-2 lost this activity subsequent to H 2 O 2 -treatment ( 
CD spectrometry analysis of recombinant protein secondary structure
The CD spectra of the recombinant proteins dissolved in EDTA-PBS are shown in Fig. 3 . Wild-type mGal-2 showed a typical β-sheet structure profile having a negative peak at the wavelength of 215 nm 3D (C57M/C75S)). However, when the C75S mutant, which retained the Cys 57 residue in its polypeptide chain, was treated with H 2 O 2 , the change in the CD spectrum was the same as that observed for wild-type mGal-2; i.e., the typical peak resulting from the rich β-sheet structure was lost after H 2 O 2 treatment but was retained when the C75S mutant was pretreated with CysNO prior to H 2 O 2 treatment (Fig. 3C ).
SDS-PAGE under reducing conditions
To test the formation of disulfide bonds between the Cys residues in the same polypeptide chain and/or two different polypeptide chains, recombinant proteins were treated with H 2 O 2 and subjected to SDS-PAGE under reducing or non-reducing conditions; i.e., with or without β-mercaptoethanol in the sample buffer, respectively. Wild-type mGal-2 and the C57M, C75S, and C57M/C75S (Cys-less)
forms of mGal-2 migrated to the position of a monomer at approximately 15 kDa under non-reducing conditions (Fig. 4A, lanes 1 (Fig. 5, lane 3) . The results for the C75S mutant, which still retains the intact Cys 57 , were similar to those of the wild-type protein regarding the appearance of the higher-molecular-weight band (Fig. 5, lanes 7-9) . However, when the two mutant proteins C57M and C57M/C75S, in which the Cys 57 residue has been mutated to Met, were examined, the highermolecular-weight bands were not observed after H 2 O 2 treatment (Fig. 5 , lanes 4-6 and 10-12).
Discussion
The polypeptide chain of mGal-2 contains two Cys residues within 130 amino acids; these two Cys residues are highly conserved among mammalian galectin-2 proteins. We have previously shown that mGal-2 loses its sugar-binding and hemagglutination ability by oxidative inactivation after treatment with H 2 O 2 and that this inactivation can be prevented by pretreatment with CysNO (23).
Furthermore, by using recombinant site-directed mutant proteins of mGal-2, i.e., C57M, C75S, and C57M/C75S, our results suggest that the two Cys residues, Cys 57 and Cys 75 , are both S-nitrosylated by treatment with CysNO (23).
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The Cys 57 residue was changed to Met instead of Ser because the C57S mutant had low solubility as previously reported (23, 29) . Because the two mutants, C57M and C75S, were both adsorbed onto the asialofetuin-agarose column and could be eluted specifically with 0.1 M lactose, with an elution profile similar to that of wild-type mGal-2 (data not shown), the amino acid substitutions did not affect the binding activity of the two mutants for β-galactoside-containing sugar structures. We also tried to express the recombinant C57A protein of mGal-2 (Cys 57 residue changed to Ala) to eliminate any potential effects of the modification of the Met residue. However, this mutant also had low solubility and it was difficult to obtain sufficient amounts of the recombinant protein, as previously reported (23, 29) .
When the ability of the recombinant proteins to be adsorbed to β-galactosides was tested after H 2 O 2 -treatment, the C57M mutant retained its ability to bind to the β-galactoside-immobilized column and was eluted specifically with lactose. In contrast, for the C75S mutant treated with H 2 O 2 , a substantial amount of the protein was found in the flow-through fraction, indicating that oxidative inactivation caused the loss of the sugar-binding ability of the protein. The finding that some remaining proteins were still adsorbed to the column likely resulted from the residual recombinant proteins not being fully inactivated because of the high concentration of the recombinant protein in the solution. However, when the C75S mutant was pretreated with CysNO prior to exposure of the protein to H 2 O 2 , the loss of the sugar-binding ability was abrogated, similar to the outcome observed for the wild-type protein as reported in our previous study (23 by CysNO treatment appears to be critical for protecting the lectin ability of mGal-2 from oxidative inactivation.
Galectins, including Gal-2, have a typical structure that is rich in β-strands (30) and have a typical β-sheet profile, with a negative peak on CD analysis at 215 nm as shown in Fig 3A for this band probably resulted from the boiling in the sample buffer without β-ME prior to SDS-PAGE.
Furthermore, from the result of the cross-linking experiment, the denaturation of the mGal-2 protein by H 2 O 2 treatment might have exposed the hydrophobic region originally folded inside the structure, thus resulting in a multimeric aggregation product. In fact, after treatment with H 2 O 2 , an insoluble precipitant was observed in the tube (not shown).
According to the X-ray crystallographic structure of human Gal-2 in complex with lactose (30), the Cys 75 residue exists on the other side of the mGal-2 molecule from the surface involved in dimer formation. Therefore, it is highly unlikely that the two Cys 75 residues in the mGal-2 homodimer form a disulfide bond in an oxidative environment. However, very small amount of artificial dimer generated by the disulfide bond formation between the two Cys 75 residues from two independent mGal-2 molecules, resulting in another very faint band for the H 2 O 2 -treated C57M mutant of mGal-2 (Fig. 4A, lane 4) , may underlie the stronger hemagglutination activity observed for the wild-type protein and C57M mutant treated with H 2 O 2 (Fig. 4, lines C (Fig. 4 , lines K and L), which could support this idea.
Gal-1 is known to form intramolecular disulfide bonds (31) and to have different biological functions depending on its redox status (28, (32) (33) (34) (35) . However, Gal-1 has also been shown to be inactivated by oxidation using H 2 O 2 , and redox regulation has been reported to be involved in the structure-function relationship of Gal-1 (28) . Furthermore, oxidation of the chicken galectin CG-1B (C14) leads to two forms of homodimers through formation of either an intrasubunit disulfide bond between Cys 2 and Cys 7 or an intersubunit disulfide bond between the two Cys 7 (36) . Thus, the function of Gal-2 in the stomach might also be regulated by its redox status, and S-nitrosylation could play an important role in this regulation. However, although the loss of lectin activity of Gal-1 is reported to result from formation of intramolecular disulfide bonds, this cannot be the case for the oxidative inactivation of mGal-2 because the C75S mutant, which only has one Cys residue remaining at the Cys 57 position, is also susceptible to inactivation by H 2 O 2 treatment.
Protein tyrosine phosphatases (PTPs) are reported to be reversibly oxidized and inactivated when cells are treated with H 2 O 2 , and they are thus suggested to be regulated by oxidization (37) . PTP1B, an enzyme of the PTP family that is important for negative regulation of the insulin receptor (38, 39) , is oxidized by H 2 O 2 at the essential residue Cys 215 (40) . This Cys 215 residue has been proposed to be reversibly inactivated to sulfenic acid (40) , and it has also been reported that this Cys residue could be irreversibly oxidized to sulfinic or sulfonic acid states (41) and that S-nitrosylation of Cys 215 protected 13 that, during reversible inactivation, Cys 215 was oxidized to sulfenic acid and then to a sulphenyl-amide structure, which forced a conformational change in the main chain of the protein (43, 44) .
Cys 57 is located in the middle of the carbohydrate-binding cassette with its side chain sulfhydryl group protruding to the side opposite that of the β-sheet that binds lactose. A conformational change similar to that in PTP1B (43, 44) induced by oxidation of the Cys 57 residue in mGal-2 could be the cause of the loss of the binding ability of mGal-2 for the β-galactoside-containing column and also the loss of the hemagglutination activity of this protein. However, considering that the typical peak resulting from the rich β-sheet structure was lost in the CD spectra of both the wild-type and C75S
proteins when treated with H 2 O 2 , and that a higher-molecular-weight complex was formed as shown It has been reported that Gal-1 is also S-nitrosylated at Cys 43 and Cys 61 (45) ; notably, Cys 61 is located at the position corresponding to Cys 57 of Gal-2. Additional experiments to determine whether or not Gal-1 is also protected from oxidative inactivation by S-nitrosylation are therefore warranted.
In conclusion, our study demonstrated that Cys 57 is likely to be responsible for oxidative inactivation of the mGal-2 protein and that protection of the sulfhydryl group of the Cys 57 in mGal-2 by S-nitrosylation might be important for maintaining mGal-2 protein function in an oxidative environment such as the gastrointestinal tract. The strong immunoreactivity observed in gastric mucous cells and the suggestion that Gal-2 might have a protective function in the gastrointestinal tract indicates that Gal-2 might have a role similar to that of Gal-3, which has been reported to play an important role in maintaining mucosal barrier function through carbohydrate-dependent interactions with cell surface mucins (46, 47) . Furthermore, because the NO generated in the gastrointestinal tract 14 has been suggested to have a protective role therein, and no substantial changes in the carbohydrate binding activity have been detected between the S-nitrosylated and non-S-nitrosylated forms of Gal-2, it is conceivable that the S-nitrosylation of Cys 57 in Gal-2 might be one of the main factors maintaining the interactions of Gal-2 with carbohydrate-containing molecules in the stomach mucus such as mucins, resulting in a more stable mucosal barrier function. To build on these results, more detailed analyses of the molecular mechanisms underlying oxidative inactivation and the means by which this inactivation is prevented by CysNO pretreatment are necessary and ongoing in our laboratory. Recombinant mGal-2 was treated with 10 mM H 2 O 2 for 2 h in the dark and was subjected to SDS-PAGE under non-reducing (A) and reducing (B) conditions. 
Figure legends
